| Revenue and Practice Management |
1 |
1 |
| Blood Transfusion |
0 |
0.74 |
| Biologic Therapy |
0 |
0.67 |
| Blood |
0 |
0.67 |
| Otolaryngology |
0 |
0.38 |
| Anemia |
0 |
0.34 |
| Food and Drug Administration (FDA) |
0 |
0.98 |
| Transfusion |
0 |
0.34 |
| Hemolytic Anemia |
0 |
0.28 |
| Sepsis |
0 |
0.21 |
| Wound Management |
0 |
0.21 |
| Hemolysis |
0 |
0.2 |
| Skin and Soft Tissue Infection |
0 |
0.17 |
| Arthralgia |
0 |
0.13 |
| Cold Agglutinin Disease |
0 |
0.99 |
| Respiratory Tract |
0 |
0.13 |
| Diarrhea |
0 |
0.12 |
| Gastroesophageal Reflux Disease |
0 |
0.12 |
| Hemoglobin |
0 |
0.12 |
| Humanized Monoclonal Antibody |
0 |
0.1 |
| Peripheral Edema |
0 |
0.1 |
| Wound Infection |
0 |
0.1 |
| Arthritis |
0 |
0.07 |
| Cancer |
0 |
0.07 |
| Cough |
0 |
0.07 |
| Dyspepsia |
0 |
0.07 |
| Edema |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Insurance |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |
| Orphan Drugs |
0 |
0.07 |
| Streptococcal Infection |
0 |
0.07 |
| Viral Infection |
0 |
0.07 |
| Wound |
0 |
0.07 |